Food supplementation as an incentive to improve pre-antiretroviral therapy clinic adherence in HIV-positive children-experience from Eastern India

Journal of Tropical Pediatrics

Volumn 58, Issue 1, 2012, Pages 31-37

  Kundu, Chanchal Kumar ^a   Samanta, Moumita ^a   Sarkar, Mihir ^a   Bhattacharyya, Subhasish ^a   Chatterjee, Sukanta ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Clinic adherence; Food incentives; HIV infection; Pre ART follow up

Indexed keywords

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORBIDITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; WEIGHT GAIN;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84856401531     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmr026     Document Type: Article

References (27)

1. Guidelines for HIV care and treatment in infants and children. NACO guidelines, November 2006. http:// www.nacoonline.org/upload/Publication/Treatment Care and support/Guidelines for HIV care (4 February 2010, date last accessed).
2. Rowe KA, Makhubele B, Hargreaves JR, et al. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tubetc Lung Dis 2005;9:263-9.
3. Amberbir A, Woldemichael K, Getachew S, et al. Predictors of adherence to antiretroviral therapy among HIV- infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 2008;8:265.
4. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-61.
5. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care 2001;13:617-29.
6. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquire Immun Deficiency Synd 2006;43(Suppl 1):S79-87.
7. Cauldbeck MB, O'Connor C, O'Connor MB, et al. Adherence to antiretroviral therapy among HIV patients in Bangalore, India. AIDS Res Therapy 2009;6:7.
8. Ross-Degnan D, Pierre-Jacques M, Zhang F, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: The clinical validity of key indicators. BMC Health Serv Res 2010;10:42.
9. Barnhoorn F, Adriaanse H. In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India. Soc Sci Med 1992;3:291-306.
10. Wright MT. The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS. AIDS Care 2000;12:703-10.
11. Liam CK, Lim KH, Wong CM, Tang BG. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis 1999;3:300-9.
12. Shah CA. Adherence to high active antiretroviral therapy (HAART) in paediatric patients infected with HIV: Issue and interventions. Indian J Pediatr 2007; 74:55-60.
13. Konkle-Parkera DJ, Erlenb JA, Dubbertc PM. Lessons learned from an HIV adherence pilot study in the Deep South. J Patient Educ Counsel 2010;78:91-6.
14. Darr ES, Cohen C, Remien R, et al. Improving adherence to antiretroviral therapy. AIDS Read 2003;3: 81-90.
15. Government of India (2008). Annual report 2007-08 New Delhi: Ministry of Health and Family Welfare. http://mohfw.nic.in (2 January 2010, date last accessed).
16. Rodger AJ, Toole M, Lalnuntluangi B, et al. DOTS-based tuberculosis treatment and control during civil conflict and an HIV epidemic, Churachandpur District. India Bulletin World Health Organization 2002;80:451-6.
17. Beith A, Eichler R, Weil D. Worldwide: Incentives for tuberculosis diagnosis and treatment. Center for Global Development. www.cgdev.org (12 April 2010, date last accessed).
18. Laxmaiah A, Sarma RKV, Rao HD, et al. Impact of mid day meal program on educational and nutritional status of school children in Karnataka. Indian Pediatrics 1999;36:1221-8.
19. Pratichi Trust (2005). Cooked mid-day meal programme in West Bengal-A study in Birbhum district. http://www.righttofoodindia.org/data/mdm_pratichi_ birbhumstudy.doc (4 April 2010, date last accessed).
20. Au JT, Kayitenkore K, Shutes E, et al. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS 2006;20:2116-8.
21. Howard AA, Arnsten JH, Lo Y, et al. Schoenbaum for the HER Study Group. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002;16:2175-82.
22. Greenaway K, Greeblott K, Hagens C. Targeted Food Assistance in the Context of HIV/AIDS. Better Practices in C-SAFE Targeted Food Programming in Malawi, Zambia, and Zimbabwe, C-SAFE, Sept 2004. http://www.c-safe.org/downloads/TFAFinal.pdf) (7 April 2010, date last accessed).
23. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002;16:1051-8.
24. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. Sahara J 2008;5: 136-43.
25. Tadios Y, Davey G. Antiretroviral treatment adherence and its correlates among people living with HIV/AIDS on highly active antiretroviral therapy in Addis Ababa, Ethiopia. Ethiop Med J 2006;44:237-44.
26. Amico K, Rivet J, Harman Jennifer, et al. Efficacy of antiretroviral therapy adherence interventions a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006;41:285-97.
27. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2007;XV:55-8.